Cargando…
Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation
Activating mutations in fibroblast growth factor receptor 2 (FGFR2) cause several craniosynostosis syndromes by affecting the proliferation and differentiation of osteoblasts, which form the calvarial bones. Osteoblasts respond to FGF with increased proliferation and inhibition of differentiation. W...
Autores principales: | Mansukhani, Alka, Ambrosetti, Davide, Holmes, Greg, Cornivelli, Lizbeth, Basilico, Claudio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2171836/ https://www.ncbi.nlm.nih.gov/pubmed/15781477 http://dx.doi.org/10.1083/jcb.200409182 |
Ejemplares similares
-
The transcription factor Sox2 is required for osteoblast self-renewal
por: Basu-Roy, Upal, et al.
Publicado: (2010) -
Signaling by Fibroblast Growth Factors (Fgf) and Fibroblast Growth Factor Receptor 2 (Fgfr2)–Activating Mutations Blocks Mineralization and Induces Apoptosis in Osteoblasts
por: Mansukhani, Alka, et al.
Publicado: (2000) -
Sox2 is required for tumor development and cancer cells proliferation in osteosarcoma
por: Maurizi, Giulia, et al.
Publicado: (2018) -
Sox2 maintains self-renewal of tumor initiating cells in osteosarcomas
por: Basu-Roy, Upal, et al.
Publicado: (2011) -
Mutant hFGF23(A12D) stimulates osteoblast differentiation through FGFR3
por: Tu, Yilin, et al.
Publicado: (2019)